Targeting urotensin II with silymarin: potential therapeutic strategies for diabetes and associated cardiovascular complications
Crossref DOI link: https://doi.org/10.1007/s11101-024-10044-y
Published Online: 2024-11-20
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sabarathinam, Sarvesh
Text and Data Mining valid from 2024-11-20
Version of Record valid from 2024-11-20
Article History
Received: 8 May 2024
Accepted: 2 November 2024
First Online: 20 November 2024
Declarations
:
: The author declares no conflict of interest in the contents of the manuscript.
: Not applicable.